IAVI Report

IAVI Report is a scientific publication that provides comprehensive and editorially independent coverage of HIV vaccine and prevention research, as well as the quest to develop vaccines and other preventive technologies to address other global health priorities. It features the voices and opinions of those leading these efforts and provides an unparalleled analysis of the latest scientific and policy research.

To access archived issues of IAVI Report dating back to 1996, click here.

Subscribe below to receive IAVI Report right to your inbox.

Questions/comments? Email us at iavireport@iavi.org.

Filter by

  • Health area

  • Locations

  • Topic

  • Year

  • Journal

  • Clear all

IAVI Report

COVID-19 is no longer an emergency, but its lessons better linger

May 24, 2023

Two new books illustrate why reflection and preparation are both essential to ensure a quicker and more equitable response to the next pandemic.

Read more

IAVI Report

Keeping it all in perspective

May 9, 2023

A view from Zambia on the shifting landscape of HIV vaccine research and the enduring optimism that characterizes one researcher’s drive.

Read more

IAVI Report

What will it take to improve access to vaccines?

April 13, 2023

Work is underway but obstacles to vaccine procurement and delivery for the next pandemic loom large.

Read more

IAVI Report

RSV vaccines: the latest success story

March 14, 2023

After decades of research, structure-based design efforts are yielding effective vaccines against respiratory syncytial virus. Jason McLellan explains the breakthroughs that paved the way.

Read more

IAVI Report

HIV with a touch of gray

February 27, 2023

More and more people living with HIV are over 50 years old, raising new questions about efforts to slow the aging process in a population of individuals on antiretroviral therapy.

Read more

IAVI Report

Is stopping SARS-CoV-2 transmission an attainable goal?

February 15, 2023

Hundreds of next-generation COVID-19 vaccines are being explored, including many that are delivered mucosally to try to prevent infection or block transmission.

Read more

IAVI Report

The end of an era

December 20, 2022

After more than 50 years, Anthony Fauci leaves behind an unparalleled legacy of championing science, particularly HIV/AIDS treatment, prevention, and cure efforts.

Read more

IAVI Report

As Ebola outbreak fades, hope for a vaccine remains

December 14, 2022

The emergence of the Sudan strain of Ebola virus in Uganda prompted a rush to get vaccine candidates ready. Expectations are it will be needed in the future.

Read more

IAVI Report

Momentum against malaria

November 29, 2022

Two vaccines are poised for delivery against this old foe. What will it take for them to change the field?

Read more

IAVI Report

Monkeypox: What went right and what went wrong?

November 15, 2022

Chris Beyrer, director of the Duke Global Health Institute and a renowned epidemiologist, discusses the monkeypox outbreak and the U.S. response.

Read more

IAVI Report

Charting the way to a cure

November 1, 2022

HIV cure researchers are energized by news of another case of remission and the development of new tools that could help researchers evaluate how well other cure strategies are working.

Read more

IAVI Report

Upping the antibody

October 13, 2022

Therapeutic antibodies against SARS-CoV-2 were developed faster than any other intervention, but their use remains limited. What lessons are there for the development of other monoclonal antibody products, including those for HIV?

Read more